CompletedNot Applicable

Endoscopic Extirpation of Benign Breast Tumors Using a Lateral Chest Wall Incision

China42 participantsStarted 2021-10-01

Plain-language summary

1. A new surgical method for breast surgery has been introduced, which involves the removal of benign breast tumors through endoscopic surgery, thereby avoiding noticeable scarring on the breast. 2. The feasibility of this surgery, key technical points, and potential complications have been analyzed.

Who can participate

Age range14 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female breast benign tumor patients
✓. Received endoscopic resection of benign breast tumors via a lateral chest wall approach.

Exclusion criteria

✕. Patients who are unable to comply with follow-up requirements
✕. Patients with a history of breast sugery
✕. Breast cancer patients

What they're measuring

Cosmetic Outcome After Endoscopic Benign Breast Tumor Resection

Timeframe: 1-3 months post-surgery.

Trial details

NCT IDNCT06472700

SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-31

View on ClinicalTrials.gov More Endoscopic Breast Surgery trials